Selected article for: "case fatality and high risk"
Author: Akay, Tankut; Kaymaz, Cihangir; Rüçhan Akar, Ahmet; Orhan, Gökçen; Yanartaş, Mehmed; Gültekin, Bahadır; Şırlak, Mustafa; Kervan, Ümit; Gezer Taş, Serpil; Biçer, Murat; Yağdı, Tahir; İspir, Selim; Doğan, Rıza
Title: Raising the bar to ultradisciplinary collaborations in management of chronic thromboembolic pulmonary hypertension
  • Cord-id: wpy15gdy
  • Document date: 2021_7_26
    • ID: wpy15gdy
    Snippet: Chronic thromboembolic pulmonary hypertension is an underdiagnosed and potentially fatal subgroup of pulmonary hypertension, if left untreated. Clinical signs include exertional dyspnea and non-specific symptoms. Diagnosis requires multimodality imaging and heart catheterization. Pulmonary endarterectomy, an open heart surgery, is the gold standard treatment of choice in selected patients in specialized centers. Targeted medical therapy and balloon pulmonary angioplasty can be effective in high-
    Document: Chronic thromboembolic pulmonary hypertension is an underdiagnosed and potentially fatal subgroup of pulmonary hypertension, if left untreated. Clinical signs include exertional dyspnea and non-specific symptoms. Diagnosis requires multimodality imaging and heart catheterization. Pulmonary endarterectomy, an open heart surgery, is the gold standard treatment of choice in selected patients in specialized centers. Targeted medical therapy and balloon pulmonary angioplasty can be effective in high-risk patients with significant comorbidities, distal pulmonary vascular obstructions, or recurrent/persistent pulmonary hypertension after pulmonary endarterectomy. Currently, there is a limited number of data regarding novel coronavirus-2019 infection in patients with chronic thromboembolic pulmonary hypertension and the changing spectrum of the disease during the pandemic. Challenging times during this outbreak due to healthcare crisis and relatively higher case-fatality rates require convergence; that is an ultradisciplinary collaboration, which crosses disciplinary and sectorial boundaries to develop integrated knowledge and new paradigms. Management strategies for the "new normal" such as virtual care, preparedness for further threats, redesigned standards and working conditions, reevaluation of specific recommendations, and online collaborations for optimal decisions for chronic thromboembolic pulmonary hypertension patients may change the poor outcomes.

    Search related documents:
    Co phrase search for related documents
    • absence presence and accurate diagnosis: 1, 2, 3, 4, 5, 6, 7
    • absence presence and acute episode: 1
    • absence presence and low mortality: 1, 2, 3, 4
    • absence presence and lung damage: 1, 2
    • absence presence and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • absolute contraindication and lung disease: 1
    • accumulate information and lung disease: 1
    • accurate diagnosis and low mortality: 1, 2
    • accurate diagnosis and lung damage: 1
    • accurate diagnosis and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute episode and lung damage: 1
    • acute episode and lung disease: 1, 2, 3, 4
    • adequate perfusion and lung damage: 1
    • long term complication and lung disease: 1
    • low mortality and lung damage: 1, 2, 3, 4
    • low mortality and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14